Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases

Metabolic Engineering - Tập 13 - Trang 588-597 - 2011
Suzanne M. Ma1,2, David E. Garcia1,3,4, Alyssa M. Redding-Johanson1,2, Gregory D. Friedland1,5, Rossana Chan1,2, Tanveer S. Batth1,6, John R. Haliburton1,2, Dylan Chivian1,2, Jay D. Keasling1,6,3, Christopher J. Petzold1,2, Taek Soon Lee1,2, Swapnil R. Chhabra1,2
1Joint BioEnergy Institute, Emeryville, CA, United States
2Physical BioSciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, United States
3Departments of Chemical Engineering and Bioengineering, University of California, Berkeley, CA, United States
4Department of Chemistry, University of California, Berkeley, CA, United States
5Biomass Science and Conversion Technology Department, Sandia National Laboratories, Livermore, CA, United States
6Physical Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, United States

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Metabolic Engineering

Tập 13

588-597

Thông tin tác giả